Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

NEW BRUNSWICK, N.J., Aug. 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Wednesday, September 15^th.  Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:30 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

SOURCE Johnson & Johnson

Related Links

www.jnj.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED